cardiovascular

Home cardiovascular

Full data from CAROLINA® outcome trial support long-term cardiovascular safety profile of Trajenta®

Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) announced full data from the CAROLINA® tri

Read More

Health

Compassionate Workplace Strategies for Grief Management

2 months   ago

Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) announced full data from the CAROLINA® tri

Empowering Women: ADPHC's HPV Vaccine Awareness Drive

2 months   ago

Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) announced full data from the CAROLINA® tri

Future of Healthcare: Dr. Jepsen's Bold Tech Vision

4 months   ago

Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) announced full data from the CAROLINA® tri

Haya's Kitchen: Reviving Palestinian Culinary Heritage

4 months   ago

Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) announced full data from the CAROLINA® tri

Winter Stomach Flu: Contagious and Increasing Cases in the

5 months   ago

Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) announced full data from the CAROLINA® tri

Sports

Messi's Argentina Triumphs in Historic Clash with Brazil

4 months   ago

Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) announced full data from the CAROLINA® tri

The Impact of Technology on Sports: Changing the Game

4 months   ago

Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) announced full data from the CAROLINA® tri

Babar Azam resigns as Pakistan captain

4 months   ago

Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) announced full data from the CAROLINA® tri